NEW YORK, Jan 30 – Illumina said Tuesday its revenue crossed the $1 million mark in 2000, but expenses rocketed as the company stepped up R&D spending.

For the year, publicly traded Illumina, a maker of microarray technologies, posted revenues of $1.3 million, compared with $474,000 in 1999.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.